Protara Therapeutics: Clinical Trials

4 recruiting, 3 completed. 3 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	3	Recruiting 3
Phase 1	2	Completed 2
Phase 3	2	Recruiting 2

Follow Protara Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer TARA-002, Investigator's Choice of Intravesical Chemotherapy - Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma	Phase 3	Recruiting	Protara Therapeutics	284	2026-05-29	2026-10-06
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support Choline Chloride for Injection, Placebo - Choline Deficiency, Liver Injury	Phase 2 / Phase 3	Recruiting	Protara Therapeutics	129	2025-12-10	2026-08-24
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age TARA-002 - Lymphatic Malformation	Phase 2	Recruiting	Protara Therapeutics	38	2023-10-18	2026-08-24
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer TARA-002 - Non-muscle Invasive Bladder Cancer	Phase 2	Recruiting	Protara Therapeutics	131	2023-09-15	2026-08-24
Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b) TARA-002 - Non-muscle Invasive Bladder Cancer	Phase 1	Completed	Protara Therapeutics	10	2023-05-08	2025-01-27
Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a) TARA-002 - Non-muscle Invasive Bladder Cancer	Phase 1	Completed	Protara Therapeutics	12	2022-03-10	2025-01-27
Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition Intestinal Failure-associated Liver Disease		Completed	Protara Therapeutics	80	2021-08-23	2023-10-03

Conditions studied

Carcinoma in Situ (4)  ·  Non-Muscle Invasive Bladder Neoplasms (4)  ·  Urinary Bladder Neoplasms (4)  ·  Choline Deficiency (2)  ·  Hyperphagia (2)  ·  Cholestasis (1)  ·  Fatty Liver (1)  ·  Intestinal Failure (1)  ·  Liver Diseases (1)  ·  Lymphatic Abnormalities (1)  ·  Neoplasms (1)

Interventions

Choline (1)  ·  Injections (1)

Countries

United States (7)  ·  Ukraine (3)  ·  Denmark (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Japan (1)  ·  Moldova (1)  ·  Poland (1)  ·  Romania (1)  ·  Taiwan (1)